Rebecca Andersson

Rebecca Andersson

Auto-generated profile, based on publicly available information

Rebecca Andersson

Stem Cell Ageing Group, Regenerative Medicine Program, The Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Cell
Verified
Journal Article
Closed access
SHSarah Hanzén
Sarah Hanzén
KVKatarina Vielfort
Katarina Vielfort
JYJunsheng Yang
Junsheng Yang
FRFriederike Roger
Friederike Roger
VAVeronica Andersson
Veronica Andersson
TNThomas Nyström
Thomas Nyström

25 August 2025 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
RARebecca Andersson
Rebecca Andersson
EMEva Mejia-Ramirez
Eva Mejia-Ramirez
Maria Carolina FlorianMaria Carolina Florian
Maria Carolina Florian

11 January 2021 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
RARebecca Andersson
Rebecca Andersson
AEAnna Maria Eisele-Bürger
Anna Maria Eisele-Bürger
SHSarah Hanzén
Sarah Hanzén
KVKatarina Vielfort
Katarina Vielfort
DÖDavid Öling
David Öling
TNThomas Nyström
Thomas Nyström
70 kDa heat shock proteins (Hsp70) are essential chaperones of the protein quality control network; vital for cellular fitness and longevity. The four cytosolic Hsp70’s in yeast, Ssa1-4, are thought to be functionally redundant but the absence of Ssa1 and Ssa2 causes a severe reduction in cellular reproduction and accelerates replicative aging. In our efforts to identify which Hsp70 activities are most important for longevity assurance, we systematically investigated the capacity of Ssa4 to carry out the different activities performed by Ssa1/2 by overproducing Ssa4 in cells lacking these Hsp70 chaperones. We found that Ssa4, when overproduced in cells lacking Ssa1/2, rescued growth, mitigated aggregate formation, restored spatial deposition of aggregates into protein inclusions, and promoted protein degradation. In contrast, Ssa4 overproduction in the Hsp70 deficient cells failed to restore the recruitment of the disaggregase Hsp104 to misfolded/aggregated proteins, to fully restore clearance of protein aggregates, and to bring back the formation of the nucleolus-associated aggregation compartment. Exchanging the nucleotide-binding domain of Ssa4 with that of Ssa1 suppressed this ‘defect’ of Ssa4. Interestingly, Ssa4 overproduction extended the short lifespan of ssa1Δ ssa2Δ mutant cells to a lifespan comparable to, or even longer than, wild type cells, demonstrating that Hsp104-dependent aggregate clearance is not a prerequisite for longevity assurance in yeast.

24 May 2017 in Essays in Biochemistry
Verified
Journal Article
Closed access
PDF file
RJRebecca Josefson
Rebecca Josefson
RARebecca Andersson
Rebecca Andersson
TNThomas Nyström
Thomas Nyström
Ageing can be defined as a gradual decline in cellular and physical functions accompanied by an increased sensitivity to the environment and risk of death. The increased risk of mortality is causally connected to a gradual, intracellular accumulation of so-called ageing factors, of which damaged and aggregated proteins are believed to be one. Such aggregated proteins also contribute to several age-related neurodegenerative disorders e.g. Alzheimer’s, Parkinson’s, and Huntington’s diseases, highlighting the importance of protein quality control (PQC) in ageing and its associated diseases. PQC consists of two interrelated systems: the temporal control system aimed at refolding, repairing, and/or removing aberrant proteins and their aggregates and the spatial control system aimed at harnessing the potential toxicity of aberrant proteins by sequestering them at specific cellular locations. The accumulation of toxic conformers of aberrant proteins during ageing is often declared to be a consequence of an incapacitated temporal PQC system—i.e. a gradual decline in the activity of chaperones and proteases. Here, we review the current knowledge on PQC in relation to ageing and highlight that the breakdown of both temporal and spatial PQC may contribute to ageing and thus comprise potential targets for therapeutic interventions of the ageing process.

4 July 2022 in The EMBO Journal
Verified
Journal Article
Closed access
RARebecca Andersson
Rebecca Andersson
Maria Carolina FlorianMaria Carolina Florian
Maria Carolina Florian

17 November 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JPJoan Pera
Joan Pera
DRDamia Romero-Moya
Damia Romero-Moya
ETEric Torralba-Sales
Eric Torralba-Sales
RARebecca Andersson
Rebecca Andersson
VGVioleta García-Hernández
Violeta García-Hernández
AGAlessandra Giorgetti
Alessandra Giorgetti
Patients with GATA2 deficiency are predisposed to developing myelodysplastic neoplasms (MDS), which can progress to acute myeloid leukemia. This progression is often associated with cytogenetic and somatic alterations. Mutations in SETBP1 and ASXL1 genes are recurrently observed in GATA2 patients, although their roles remain poorly understood. Here we develop a hiPSC-based system to investigate the impact of SETBP1 and ASXL1 mutations in GATA2 deficiency. Using precise genome editing, we recreate stepwise mutational trajectories observed in GATA2-related MDS. We demonstrate that GATA2 mutation has limited impact on hematopoietic progenitors, while the co-occurrence of SETBP1 or ASXL1 mutations impairs myeloid differentiation. The combination of all three mutations severely depletes myeloid progenitors, recapitulating GATA2-related MDS and highlighting their synergistic interplay. Notably, SETBP1 mutation plays a dominant role in establishing a stable chromatin accessibility landscape, even when co-occurring with ASXL1. Our study establishes an iPSC-based model of GATA2 deficiency, offering new insights into myeloid disease progression and a platform for testing future therapeutic strategies.